145 related articles for article (PubMed ID: 28555140)
1. Tripartite Motif-Containing Protein 22 Interacts with Class II Transactivator and Orchestrates Its Recruitment in Nuclear Bodies Containing TRIM19/PML and Cyclin T1.
Forlani G; Tosi G; Turrini F; Poli G; Vicenzi E; Accolla RS
Front Immunol; 2017; 8():564. PubMed ID: 28555140
[TBL] [Abstract][Full Text] [Related]
2. The MHC-II transactivator CIITA inhibits Tat function and HIV-1 replication in human myeloid cells.
Forlani G; Turrini F; Ghezzi S; Tedeschi A; Poli G; Accolla RS; Tosi G
J Transl Med; 2016 Apr; 14():94. PubMed ID: 27089879
[TBL] [Abstract][Full Text] [Related]
3. TRIM22 inhibits HIV-1 transcription independently of its E3 ubiquitin ligase activity, Tat, and NF-kappaB-responsive long terminal repeat elements.
Kajaste-Rudnitski A; Marelli SS; Pultrone C; Pertel T; Uchil PD; Mechti N; Mothes W; Poli G; Luban J; Vicenzi E
J Virol; 2011 May; 85(10):5183-96. PubMed ID: 21345949
[TBL] [Abstract][Full Text] [Related]
4. Tripartite Motif 22 and Class II Transactivator Restriction Factors: Unveiling Their Concerted Action against Retroviruses.
Forlani G; Accolla RS
Front Immunol; 2017; 8():1362. PubMed ID: 29093716
[TBL] [Abstract][Full Text] [Related]
5. The interferon-stimulated gene TRIM22: A double-edged sword in HIV-1 infection.
Vicenzi E; Poli G
Cytokine Growth Factor Rev; 2018 Apr; 40():40-47. PubMed ID: 29650252
[TBL] [Abstract][Full Text] [Related]
6. The interferon-induced antiviral protein PML (TRIM19) promotes the restriction and transcriptional silencing of lentiviruses in a context-specific, isoform-specific fashion.
Masroori N; Merindol N; Berthoux L
Retrovirology; 2016 Mar; 13():19. PubMed ID: 27000403
[TBL] [Abstract][Full Text] [Related]
7. Restriction factors in human retrovirus infections and the unprecedented case of CIITA as link of intrinsic and adaptive immunity against HTLV-1.
Forlani G; Shallak M; Ramia E; Tedeschi A; Accolla RS
Retrovirology; 2019 Nov; 16(1):34. PubMed ID: 31783769
[TBL] [Abstract][Full Text] [Related]
8. Reversible Human Immunodeficiency Virus Type-1 Latency in Primary Human Monocyte-Derived Macrophages Induced by Sustained M1 Polarization.
Graziano F; Aimola G; Forlani G; Turrini F; Accolla RS; Vicenzi E; Poli G
Sci Rep; 2018 Sep; 8(1):14249. PubMed ID: 30250078
[TBL] [Abstract][Full Text] [Related]
9. Tripartite Motif 22 (TRIM22) protein restricts herpes simplex virus 1 by epigenetic silencing of viral immediate-early genes.
Reddi TS; Merkl PE; Lim SY; Letvin NL; Knipe DM
PLoS Pathog; 2021 Feb; 17(2):e1009281. PubMed ID: 33524065
[TBL] [Abstract][Full Text] [Related]
10. HIV-1 transcriptional silencing caused by TRIM22 inhibition of Sp1 binding to the viral promoter.
Turrini F; Marelli S; Kajaste-Rudnitski A; Lusic M; Van Lint C; Das AT; Harwig A; Berkhout B; Vicenzi E
Retrovirology; 2015 Dec; 12():104. PubMed ID: 26683615
[TBL] [Abstract][Full Text] [Related]
11. Recruitment of human cyclin T1 to nuclear bodies through direct interaction with the PML protein.
Marcello A; Ferrari A; Pellegrini V; Pegoraro G; Lusic M; Beltram F; Giacca M
EMBO J; 2003 May; 22(9):2156-66. PubMed ID: 12727882
[TBL] [Abstract][Full Text] [Related]
12. The HLA class II transcriptional activator blocks the function of HIV-1 Tat and inhibits viral replication.
Accolla RS; Mazza S; De Lerma Barbaro A; De Maria A; Tosi G
Eur J Immunol; 2002 Oct; 32(10):2783-91. PubMed ID: 12355430
[TBL] [Abstract][Full Text] [Related]
13. PML/TRIM19-Dependent Inhibition of Retroviral Reverse-Transcription by Daxx.
Dutrieux J; Maarifi G; Portilho DM; Arhel NJ; Chelbi-Alix MK; Nisole S
PLoS Pathog; 2015 Nov; 11(11):e1005280. PubMed ID: 26566030
[TBL] [Abstract][Full Text] [Related]
14. p300, but not PCAF, collaborates with IRF-1 in stimulating TRIM22 expression independently of its histone acetyltransferase activity.
Gao B; Xu W; Zhong L; Zhang Q; Su Y; Xiong S
Eur J Immunol; 2013 Aug; 43(8):2174-84. PubMed ID: 23670564
[TBL] [Abstract][Full Text] [Related]
15. Dynamic localization of tripartite motif-containing 22 in nuclear and nucleolar bodies.
Sivaramakrishnan G; Sun Y; Tan SK; Lin VC
Exp Cell Res; 2009 May; 315(8):1521-32. PubMed ID: 19331816
[TBL] [Abstract][Full Text] [Related]
16. Reciprocal modulation of transcriptional activities between HIV-1 Tat and MHC class II transactivator CIITA.
Okamoto H; Asamitsu K; Nishimura H; Kamatani N; Okamoto T
Biochem Biophys Res Commun; 2000 Dec; 279(2):494-9. PubMed ID: 11118314
[TBL] [Abstract][Full Text] [Related]
17. Gene Knockout Shows That PML (TRIM19) Does Not Restrict the Early Stages of HIV-1 Infection in Human Cell Lines.
Masroori N; Cherry P; Merindol N; Li JX; Dufour C; Poulain L; Plourde MB; Berthoux L
mSphere; 2017; 2(3):. PubMed ID: 28656178
[TBL] [Abstract][Full Text] [Related]
18. The Major Histocompatibility Complex Class II Transactivator CIITA Inhibits the Persistent Activation of NF-κB by the Human T Cell Lymphotropic Virus Type 1 Tax-1 Oncoprotein.
Forlani G; Abdallah R; Accolla RS; Tosi G
J Virol; 2016 Jan; 90(7):3708-21. PubMed ID: 26792751
[TBL] [Abstract][Full Text] [Related]
19. A 5' extended IFN-stimulating response element is crucial for IFN-gamma-induced tripartite motif 22 expression via interaction with IFN regulatory factor-1.
Gao B; Wang Y; Xu W; Duan Z; Xiong S
J Immunol; 2010 Aug; 185(4):2314-23. PubMed ID: 20631312
[TBL] [Abstract][Full Text] [Related]
20. TRIM22 negatively regulates MHC-II expression.
Inoue A; Watanabe M; Kondo T; Hirano S; Hatakeyama S
Biochim Biophys Acta Mol Cell Res; 2022 Oct; 1869(10):119318. PubMed ID: 35777501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
